Form 4: Arthur J. Gallagher & Co. Executive Acquires Stock Options
SEC Form 4
Thomas Joseph Gallagher, President of Arthur J. Gallagher & Co., reports acquisition of stock options.
Summary
- On March 1, 2025, Thomas Joseph Gallagher, President of Arthur J. Gallagher & Co., acquired 14,876 non-qualified stock options.
- The exercise price of these options is $337.74.
- The options become exercisable in three equal installments on the 3rd, 4th, and 5th anniversaries of the grant date.
- The expiration date for these options is March 1, 2032.
- Following the transaction, Gallagher directly owns 14,876 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of stock option grants, which is neither overtly positive nor negative.
Positives
- The acquisition of stock options by a company executive can be seen as a positive sign, indicating confidence in the company's future performance.
Future Outlook
The document does not contain specific forward-looking statements beyond the vesting schedule of the stock options.
Industry Context
This filing is a routine disclosure related to executive compensation and is common in the insurance brokerage industry. Monitoring insider transactions can provide insights into management's sentiment about the company's prospects.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in the insurance brokerage industry.
- Companies like Marsh & McLennan, Aon, and Willis Towers Watson also utilize stock options as part of their compensation packages.
- The vesting schedules and exercise prices are typically structured to align executive interests with long-term shareholder value.
Stakeholder Impact
- The stock option grant aligns the executive's interests with those of the shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 03/01/2025 | Date of the stock option transaction. |
| 02/28/2025 | Closing price of Gallagher common stock used to determine exercise price. |
| 03/01/2028 | First vesting date for one-third of the stock options. |
| 03/01/2029 | Second vesting date for one-third of the stock options. |
| 03/01/2030 | Third vesting date for one-third of the stock options. |
| 03/01/2032 | Expiration date of the stock options. |
| 03/05/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.